Logo image
Preliminary evidence for a postsynaptic action of β-bungarotoxin in mammalian skeletal muscle
Journal article   Peer reviewed

Preliminary evidence for a postsynaptic action of β-bungarotoxin in mammalian skeletal muscle

R.J. Storella, A.L. Schouchoff, M. Fujii, J. Hill, J.E. Fletcher, M.-S. Jiang and L.A. Smith
Toxicon (Oxford), v 30(3), pp 349-354
1992
PMID: 1529466

Abstract

Two hours after treatment with β-bungarotoxin (0.34–0.4 μM), when there was complete neuromuscular block, the peak contracture response to 50 μM succinylcholine was significantly reduced by about 35% in the mouse phrenic nerve-diaphragm preparation. Additionally, significant phospholipase A 2 activity was detected on primary cell cultures from skeletal muscle which were incubated for 2 hr with concentrations of β-bungarotoxin ≥ 0.1 μM. Thus, β-bungarotoxin appears to have pharmacologically and biochemically detectable postsynaptic actions in mammalian muscle systems.

Metrics

8 Record Views
5 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Pharmacology & Pharmacy
Toxicology
Logo image